Frozen--thawed cleavage-stage embryo transfer cycles after previous GnRH agonist or antagonist stimulation

Bahçeci, Mustafa; Ulug, Ulun; Erden, Halit Fırat; Tosun, Suleyman; Çiray, Nadir
January 2009
Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jan2009, Vol. 18 Issue 1, p67
Academic Journal
This study presents the results of fresh and frozen--thawed embryo transfers in women undergoing IVF with gonadotrophin-releasing hormone (GnRH) agonists and GnRH antagonists. By evaluating cycle outcomes, the impact of two different protocols on the endometrium was indirectly evaluated. For 714 women, embryos were frozen following day-3 fresh embryo transfer and the outcome of those fresh cycles (329 agonist cycles and 290 antagonist cycles) and subsequent frozen--thawed embryo transfer (91 agonist cycles and 104 antagonist cycles) were evaluated. Peak oestradiol concentrations of both groups were similar; however, significantly more oocytes were retrieved and more embryos frozen in the agonist versus antagonist group (both P = 0.0001). In fresh embryo transfer cycles, implantation and pregnancy rates in the agonist versus antagonist group were 42.3% versus 32.0% (P = 0.0001) and 68.6% versus 58.2% (P = 0.009) respectively. However, neither implantation or pregnancy rate significantly differed among frozen--thawed embryo transfer cycles between the two groups (21.4% versus 23.5% and 52.2% versus 52.4% respectively). These results suggest that ovarian stimulation parameter outcomes of GnRH antagonist cycles were not inferior to GnRH agonist cycles, therefore reduced embryo implantation and pregnancy rates in GnRH antagonist cycles can be attributable to possible deleterious effects on the endometrium.


Related Articles

  • Early Cleavage of Zygote Not Accurate in Predicting Embryo Implantation Potential.  // Fertility Weekly;8/10/2009, p9 

    The article reports on the results of a study led by Wen-Jui Yang in Taiwan to test whether early cleavage was a strong indicator of pregnancy in patients undergoing either a GnRH agonists protocol or antagonist protocol for in vitro fertilization (IVF) and ICSI. The study includes 534 patients...

  • Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists. Efstratios M. Kolibianakis; Evangelos G. Papanikolaou; Michel Camus; Herman Tournaye; André C. Van Steirteghem; Paul Devroey // Human Reproduction;Apr2006, Vol. 21 Issue 4, p1012 

    BACKGROUND: The purpose of this study was to evaluate prospectively the association between the achievement of ongoing pregnancy and the time interval from the end of menstruation until the administration of HCG (menstruation-free interval) in patients treated by IVF. METHODS: A fixed dose of...

  • In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF. Trifon Lainas; John Zorzovilis; George Petsas; Georgia Stavropoulou; Haris Cazlaris; Vassiliki Daskalaki; George Lainas; Efthymia Alexopoulou // Human Reproduction;Sep2005, Vol. 20 Issue 9, p2426 

    BACKGROUND: The purpose of the study was to assess ongoing pregnancy rates across groups of patients treated by IVF, which were defined according to criteria aimed at the prevention of premature LH surge and used for initiating GnRH antagonist. METHODS: This is a prospective observational cohort...

  • Subpopulations of human granulosa--luteal cells obtained from gonadotropin- or.... Gersak, Ksenija; Tomazevic, Tomaz // Journal of Assisted Reproduction & Genetics;Oct99, Vol. 16 Issue 9, p488 

    Differentiates granulated--luteal cells obtained from gonadotropin- from gonadotropin-releasing hormone (GnRH) in in vitro fertilization--embryo transfer cycles. Function of corpus luteum; Occurrence of abnormal luteal function; Cause of luteal defect; Effect of GnRH agonist on human...

  • Benefits of luteinizing hormone activity in ovarian stimulation for IVF. Venetis, C. A; Kolibianakis, E. M.; Tarlatzi, T. B.; Tarlatzis, B. C. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;2009 Supplement 2, Vol. 18 Issue S2, pS31 

    Knowledge of the physiology of folliculogenesis has led to a better understanding of the role of LH activity in this process. This role has been investigated in the setting of ovarian stimulation and several treatment modalities have been proposed. LH activity can be provided in the forms of:...

  • Ultrasound diagnosed adenomyosis has a negative impact on successful implantation following GnRH antagonist IVF treatment. Thalluri, V.; Tremellen, K.P. // Human Reproduction;Dec2012, Vol. 27 Issue 12, p3487 

    STUDY QUESTION Does the presence of ultrasound diagnosed adenomyosis interfere with successful implantation in patients undergoing IVF treatment with GnRH antagonist ovarian stimulation? SUMMARY ANSWER The presence of ultrasound diagnosed adenomyosis was associated with a significant reduction...

  • Rescue in vitro fertilization using a GnRH antagonist in hyper-responders from gonadotropin intrauterine insemination (IUI) cycles. Balayla, Jacques; Granger, Louis; St-Michel, Pierre; Villeneuve, Marc; Fontaine, Jean-Yves; Desrosiers, Pascal; Dahdouh, Elias // Journal of Assisted Reproduction & Genetics;Jul2013, Vol. 30 Issue 6, p773 

    Objective: To evaluate the outcomes in the conversion of high-response gonadotropin intrauterine insemination (IUI) cycles to 'rescue' in vitro fertilization (IVF) using a Gonadotropin-Releasing Hormone (GnRH) antagonist, with regards to implantation rates, pregnancy rates, cost, and ovarian...

  • FSH: what is the highest dose for ovarian stimulation that makes sense on an evidence-based level? Dorn, Christoph // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2005, Vol. 11 Issue 5, p555 

    The widely applied practice of a gonadotrophin dose increase in case of low response is not on an evidence-based level and not efficacious. All known comparative studies failed to show a difference in favour of the high-dose group regarding their pregnancy rate per embryo transfer. However if...

  • Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages. Yan Huang; En-yin Wang; Qing-yun Du; Yu-jing Xiong; Xiao-yi Guo; Yi-ping Yu; Ying-pu Sun // Reproductive Biology & Endocrinology;Aug2015, Vol. 13 Issue 1, p1 

    Background: The effect of progesterone elevation (PE) on the day of human chorionic gonadotropin (hCG) administration on the pregnancy outcomes of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles is a matter of ongoing debate. The replacement of cleavage-stage embryos...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics